Lupin's UCD Drug Approved by FDA

Lupin Limited just snagged the green light from the U.S. FDA for its Glycerol Phenylbutyrate Oral Liquid, a fancy name for a drug that helps manage urea cycle disorders (UCDs) when diet alone doesn't cut it. This liquid elixir matches the reference drug Ravicti, which raked in a cool $337 million last year. What does it mean for you? If you're one of the folks dealing with UCDs, there's now another option on the pharmacy shelf that could be easier on your wallet. More choices mean better access to the meds you need.